Healthcare provider profile · identity verified

John Eric Lacy, M.D.

Internal Medicine · GREENVILLE, SC · NPI 1992964159

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	975	279
Amlodipine Besylate	Amlodipine Besylate	699	203
Atorvastatin Calcium	Atorvastatin Calcium	505	144
Levothyroxine Sodium	Levothyroxine Sodium	348	98
Hydrochlorothiazide	Hydrochlorothiazide	347	100
Omeprazole	Omeprazole	325	87
Metformin Hcl	Metformin Hcl	321	87
Losartan Potassium	Losartan Potassium	313	87
Lisinopril	Lisinopril	251	67
Montelukast Sodium	Montelukast Sodium	214	67
Trazodone Hcl	Trazodone Hcl	194	62
Metoprolol Succinate	Metoprolol Succinate	184	63
Tamsulosin Hcl	Tamsulosin Hcl	172	52
Valsartan	Valsartan	155	44
Allopurinol	Allopurinol	154	44
Jardiance	Empagliflozin	150	39
Metformin Hcl Er	Metformin Hcl	149	49
Albuterol Sulfate Hfa	Albuterol Sulfate	146	48
Pravastatin Sodium	Pravastatin Sodium	140	40
Gabapentin	Gabapentin	139	55
Escitalopram Oxalate	Escitalopram Oxalate	137	47
Metoprolol Tartrate	Metoprolol Tartrate	131	36
Simvastatin	Simvastatin	131	36
Ezetimibe	Ezetimibe	119	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	118	31
Fluticasone Propionate	Fluticasone Propionate	117	52
Pantoprazole Sodium	Pantoprazole Sodium	108	38
Potassium Chloride	Potassium Chloride	102	35
Alendronate Sodium	Alendronate Sodium	100	33
Duloxetine Hcl	Duloxetine Hcl	98	39
Famotidine	Famotidine	88	24
Ozempic	Semaglutide	77	22
Citalopram Hbr	Citalopram Hydrobromide	74	22
Hydralazine Hcl	Hydralazine Hcl	73	20
Donepezil Hcl	Donepezil Hcl	71	26
Atenolol	Atenolol	70	19
Mirtazapine	Mirtazapine	68	24
Carvedilol	Carvedilol	67	23
Furosemide	Furosemide	67	28
Nebivolol Hcl	Nebivolol Hcl	67	19
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	67	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	21
Rybelsus	Semaglutide	65	19
Sertraline Hcl	Sertraline Hcl	63	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	60	20
Finasteride	Finasteride	58	18
Spironolactone	Spironolactone	54	17
Tresiba Flextouch U-100	Insulin Degludec	50	14
Buspirone Hcl	Buspirone Hcl	49	17
Lorazepam	Lorazepam	49	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	48	17
Benazepril Hcl	Benazepril Hcl	44	12
Januvia	Sitagliptin Phosphate	42	11
Meclizine Hcl	Meclizine Hcl	40	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	14
Chlorthalidone	Chlorthalidone	36	suppressed
Novolog Flexpen	Insulin Aspart	36	11
Methylprednisolone	Methylprednisolone	35	30
Tresiba Flextouch U-200	Insulin Degludec	35	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	33	13
Klor-Con M20	Potassium Chloride	32	11
Bupropion Xl	Bupropion Hcl	31	12
Nifedipine Er	Nifedipine	31	suppressed
Pregabalin	Pregabalin	30	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	29	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Sildenafil Citrate	Sildenafil Citrate	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Levofloxacin	Levofloxacin	26	23
Testosterone	Testosterone	26	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Azithromycin	Azithromycin	24	24
Clonidine Hcl	Clonidine Hcl	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Xarelto	Rivaroxaban	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	18
Eliquis	Apixaban	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	12
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Ramipril	Ramipril	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Baclofen	Baclofen	18	18
Glipizide Er	Glipizide	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Klor-Con M10	Potassium Chloride	15	suppressed
Nystatin	Nystatin	15	suppressed
Ondansetron Odt	Ondansetron	15	11
Synthroid	Levothyroxine Sodium	15	suppressed
Victoza 3-Pak	Liraglutide	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Torsemide	Torsemide	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Invokana	Canagliflozin	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Prednisone	Prednisone	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error